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Hyperpolarization of Amino Acid Derivatives in 
Water for Biological Applications 
S. Glöggler,a S. Wagnerb and L.-S. Boucharda, c,d,
We report on the successful synthesis and hyperpolarization of N-unprotected α-amino acid 
ethyl acrylate esters and extensively, on an alanine derivative hyperpolarized by PHIP (4.4±1% 
13C-polarization), meeting required levels for in vivo detection. Using water as solvent 
increases biocompatibility and the absence of N-protection is expected to maintain biological 
activity. 
Introduction 
NMR is an established analytical technique broadly used 
in chemistry and biomedicine, recognized as a highly effective, yet 
insensitive, diagnostic tool.  This lack of sensitivity prohibits the 
detection of low concentration molecules, such as metabolites or 
pharmaceuticals, within manageable scanning times. Various 
hyperpolarization techniques have been developed to overcome the 
sensitivity problem. These techniques rely on the creation of large 
non-equilibrium population differences of nuclear spin polarization 
in the magnetic energy sublevels of the nuclear spins.  This 
population difference is substantially larger than the thermal 
(Boltzmann) population difference, potentially resulting in signal 
enhancements over 10,000 fold. This tremendous increase in signal 
offers the potential to design new contrast agents for improved 
disease marker detection with MRI.  
Different hyperpolarization methods have been applied to 
pursue this goal.1-11 For example, hyperpolarized xenon by means of 
spin exchange optical pumping has been successfully implemented 
in lung imaging and has also been caged in functionalized 
cryptophane structures to act as a biosensor.1-5 Dynamic Nulear 
Polarization (DNP), in which the polarization from an unpaired 
electron in a free radical is transferred to the nuclei, has been 
employed to hyperpolarize biologically active molecules and pursue 
their metabolism in vivo by monitoring the subsequent 
transformation of hyperpolarized products.6-11 DNP has been the 
most utilized hyperpolarization to date for metabolic image; it is 
biocompatible and has recently been adopted in patient studies.11  
The PHIP technique12-13 is another very promising and 
more cost-effective hyperpolarization method, however, it requires 
the hydrogenation of a substrate molecule with an unsaturated bond 
using para-hydrogen (p-H2), followed by a subsequent conversion of 
the nuclear spin singlet to a triplet state to induce polarizations.12-13 
The production of p-H2 depends on cooling hydrogen gas to low 
temperatures in the presense of a catalyst. 12-13 The cooling of 
hydrogen gas to 25K can yield nearly 100% enrichment and thus, an 
almost pure quantum singlet spin order.12-15 The application of PHIP 
to biomolecular imaging builds on efficient pairwise addition of p-
H2 to the substrate in aqueous solution. Based on the scarcity of 
discovered biological relevant substrates suited to be hyperpolarized 
in biologically compatible solvents, such as water, the application to 
living systems has lagged behind other methods. Molecular tracers 
must be designed and synthesized for each application of interest to 
incorporate viable water solubility and a hyperpolarizable PHIP 
moiety. The design of these molecules must provide a binding site 
for the p-H2 adjacent to a heteronuclear species, such as 13C, to 
transfer the polarization. The heteronuclear recipient generally 
exhibits longer relaxation times allowing for extended in vivo 
traceability.16 
The substrates that have been hyperpolarized to significant 
extents are mostly metabolites (or derivatives thereof) involved in 
glycolysis or the Kreb’s cycle. While such applications to metabolic 
imaging are extremely promising, it is desirable to expand the range 
of molecular probes available to experimentalists and eventually for 
diagnostic purposes, so that additional physiological phenomenons 
can be explored, such as cell signaling, enzyme metabolism, and 
binding events to a target. 
Recently, PHIP was applied to hyperpolarize select 
metabolites for contrast-enhanced angiography in animals.16-20 
Biologically active and biocompatible molecules that can be traced 
inside an organism provide the essential groundwork for molecular 
imaging.21-24 A synthetic compound has also been used to detect the 
presense of fatty plaque in mice through chemical shift alteration 
induced by binding.25 Among candidate tracer molecules, amino 
acids and their derivatives are of particular interest because they can 
potentially serve as tracers for metabolism or as indicators of binding 
events. The amino acids can then act as building blocks to produce 
peptides. One recent achievement towards the investigation of 
binding events includes the functionalization of a peptide, sunflower 
trypsin inhibitor 1, which was hyperpolarized while the enzyme 
remained intact.26 Molecular interactions occur in the range of 
seconds to a few minutes within the decay time of the 
hyperpolarized signal. For example, DNP polarized glutamine is 
taken up and metabolized to glutamate within 20 seconds after 
injection in vivo by cancer cells and binding of cancer targeting 
peptides were reported in vivo within one to a few minutes.27-29 
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Most PHIP investigations with amino acids and their 
derivatives have been performed in non-aqueous solvents, such as 
chloroform, methanol or acetone, predominantly with protected 
amine functional groups.  These studies30-34 not only yielded lower 
polarization than reported here (in particular, a 13C polarization of 
1.3% in Ref. [33]), but more importantly, the reaction exhibited little 
to no polarization in aqueous solution. We note that most of the 
previous studies were performed with 50% p-H2 enrichment. Taking 
this into account, an increase in polarization by a factor of 3 can be 
estimated.35 The lack of sufficient polarization however will prevent 
any successful clinical application. Also, to maintain biological 
activity and biocompatibility respectively, the design of biomarkers 
with active amine sites is desirable and making the use of water as 
solvent preferable (see discussion on amino acid polarization in 
Supplementary Information).   
In this article, we show the synthesis of N-unprotected α-
amino acid ethyl acrylate esters and in particular, an alanine 
derivative, for which the highest 13C polarization in D2O to date was 
achieved when the ester was treated with para-hydrogen in the 
presence of a water-soluble rhodium complex, i.e. 
bis(norbornadiene) rhodium(I) tetrafluoroborate (Sigma-Aldrich). 
Utilizing a comparable compound, a 10% 13C-polarization with 
2-hydroxyethylacrylate (HEA), and a polarization of 4.4±1% was 
obtained with our amino acid derivative based on alanine (nearly 
100% p-H2 enrichment). The measured polarization level can be  
further improved by reducing the transport time to the magnet 
(currently 20 s), as explained below. 
HEA was chosen as the polarization-carrying moiety to 
obtain hyperpolarization in amino acid derivatives based on prior 
successes in PHIP experiments and because the hyperpolarized 
product, hydroxyethyl propionate (HEP) has an in vivo LD50 value 
corresponding to that of fumarate, a metabolite naturally occurring in 
the citric acid cycle.36 (For further discussion of toxic and metabolic 
behaviour please refer to the supplementary information.)  This 
research represents the first significant step toward practical in vivo 
applications of PHIP techniques for peptides.  The crucial 
contributions made by this work are three-fold: 1) generation of 
unprecedented 13C nuclear spin polarization of amino acid 
derivatives to levels sufficient for in vivo applications, 2) use of 
(deuterated) water as the solvent to increase biocompatibility; and 3) 
design of N-unprotected amino acid derivatives with 
hyperpolarizable PHIP moieties that can function as peptide building 
blocks to produce biologically active peptides. 
 
Results and Discussion 
 
When designing a potential hyperpolarized biomarker, the 
critical factors are fast delivery to the target location inside the 
organism, as well as , sufficiently long retention of the polarization 
For 13C polarization spefically, the time to the target needs to be 
within one to two minutes. The timescale over which nuclear spins 
depolarize and return to their thermal equilibrium is the longitudinal 
relaxation time (T1).  As reported here, spin polarization is defined 
as: 
 
P = (Nβ-Nα) · (Nβ+Nα)-1,  
in which Nα denotes the number of spins in the higher energy state of 
the nuclear magnetic energy sublevels and Nβ the number of spins in 
the lower energy state for a two-level system that is valid if spin I = 
½ (e.g., for 1H and 13C nuclei). In the following, polarization will be 
given as a percentage P · 100%. Essentially, a tracer that achieves 
both high polarization and a long T1 is what we are aiming for.   
  
  
  
Figure 1. (a) Synthesis of the protected amino acid ethyl acrylate 
esters from N-protected amino acids and hydroxyethylacrylate (b) 
Deprotection of the amine function with TFA yields N-unprotected 
α-amino acid derivatives.  (c) Hydrogenation with para-hydrogen in 
deuterated water catalyzed by a water-soluble rhodium complex. 
 
HEA has been frequently used in PHIP hyperpolarization 
studies, including at times as a MRI contrast agent for angiography 
in animals.16-20-31  It is commercially available in both, deuterated- 
and 13C-labelled forms. When partly deuterated, one of the 13C 
nuclei of the acrylate functionality possesses a T1 close to two 
minutes in deuterated solvents in low magnetic fields, and a 
polarization of P > 10 % is routinely detected in the magnet through 
the use of a custom-built polarizer apparatus.16,37  The α-amino acids 
derivatized in this study were chosen to be glycine, alanine and 
glutamine for their potential relevance as tracers in molecular 
imaging experiments.  Glycine is the simplest proteinogenic amino 
acid and has recently been identified as a metabolite associated with 
cancer proliferation, it is used for cellular purine synthesis, a 
building block for nucleic acids and thus, DNA.38  The metabolic 
pathways of alanine are closely connected to pyruvate, a metabolite 
often overexpressed in cancer cells.9  Glutamine is currently being 
discussed as a potential tracer in MRI studies as it is overexpressed 
in some cancer cells.39  Multiple studies with positron emission 
tomography tracers or amino acid modified gadolinium complexes 
indicated that significantly altered amino acids, even with 
considerably larger modifications than presented here, are still 
biologically active and internalized by cells according to the same 
pathways as amino acids on a minute timescale. This has been 
evaluated for alanine and glutamine derivatives.39-42  
The amino acid derivatives used in our experiments 
(Figure 1) were synthesized, as detailed in the Methods section.  The 
hyperpolarized products yielded amino acid ethyl propionate esters 
(1c–3c; Figure 1c) that show a characteristic triplet and quartet at 1.0 
and 2.4 ppm, respectively, in the 1H NMR spectrum for the 
investigated substrates (Figure 2). Typical yields for the proton 
experiments ranged from 5 to 10% for unoptimized mixing 
conditions. The reported polarization values have been normalized to 
the yield. The observed phase pattern corresponds to Iz-Sz 
magnetization as expected from an ALTADENA experiment but is 
shown in magnitude mode for comparison with the thermal 
spectrum.43 Hydrogenation experiments were conducted at two 
different temperatures: 20 °C and 80 °C. 
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Figure 2. Hydrogenation of glycine derivative in D2O using water-
soluble rhodium complex.  Top trace: Hyperpolarized section of the 
proton spectrum following hydrogenation performed with p-H2 at 80 
°C.  After the esters were treated with p-H2, physical transport of the 
sample to the NMR magnet took 10 s.  Bottom trace: Thermal 
polarization of propionate protons following equilibration at 14.1 T 
and 20 °C.  The bottom trace has been magnified by a factor of 64 
and both spectra are shown in magnitude (absolute value) mode.  
Peaks attributed to the decomposition products of the catalyst are 
marked with an asterisk. The level of polarization in the 
hyperpolarized product corresponds to 0.73 % after transport. 
 
Notably, the proton polarization of all amino acid 
derivatives was at least a factor of 2 higher at the elevated 
temperature (Table 1).  Hyperpolarization of the glycine and alanine  
 
Table 1. Proton polarization of the hyperpolarized amino acid 
derivatives 
  Hyperpolarized species                         Polarization at  
       20 °C [%]    
Polarization at  
   80 °C [%]    
  
1c  
             
         0.33 
 
     0.73 
 
 
2c  
 
 
 
 
3c             
 
 
 
4b 
 
 
5a  
             
 
         0.13 
 
 
 
          0.02 
 
 
 
 
          0.48 
 
 
          0.74  
              
 
 
     0.70 
 
 
 
     0.52 
 
 
 
 
     1.02 
 
 
     1.26 
derivatives, both containing a single amine function, resulted in a 
measured proton polarization of P(gly)=0.73% and P(ala)=0.70 %. 
All experiments were performed at a pH = 6.5 ± 0.5 as indicated by 
pH test paper. A large difference from a neutral pH may result in a 
better polarization but has a disadvantage: the polarization product 
requires dilution in buffer prior to injection to regulate the pH value 
to a biocompatible level.  Dilution of the compounds can result in 
concentrations of the potential tracers that are too low.  Table 1 
summarizes the determined proton polarization values of all 
hyperpolarized molecules investigated.  The T1 relaxation times of 
the protons range between 2–6 s (see Supplementary Information) at 
the detection field.  However, due to the transportation time between 
polarization and detection (10 s), significant polarization is lost 
before acquisition. Since T1 is not constant during the transportation 
process from earth’s magnetic field into high magnetic field, the loss  
in polarization cannot be precisely quantified here but is considered 
to be substantial on account of validation through 13C transfer 
experiments. An example 1H NMR spectrum of the hyperpolarized 
region of the glycine derivative is shown in Figure 2.  Here, a signal 
enhancement of  ≈200 relative to the thermal polarized signal at B0 = 
14.1 T (600 MHz proton frequency) can be clearly discerned. In high 
temperature experiments, additional hyperpolarized peaks can be 
identified, which are attributed to the decomposition of the catalyst.  
These peaks are discussed in more detail in the Supplementary 
Information.   
For the hyperpolarized glutamine derivative, which 
contains two unprotected amine groups, proton polarization of only 
0.02 % was observed at 20°C, but 0.52% was observed at 80°C.  
Previous studies on rhodium transition metal complexes with 
phosphine ligands indicate that catalytic activity may be reduced if 
unprotected amine groups are present in the reaction mixture during 
hydrogenation; the observed trend in polarization can be deduced as 
follows: The reaction proceeds faster with increasing temperature 
and the quantum correlation of para-hydrogen used to create 
hyperpolarization can be transferred more effectively.  This effect is 
contrary to the progressive deactivation of the catalyst by free amine 
groups, which leads to catalyst decomposition slowing down the 
addition of para-hydrogen and leading to a decrease in observable 
proton polarization.44 In this case, the catalyst is sacrificed in the 
reaction to produce more product carrying a higher polarization. 
To verify the effect of the free amine on the achieved 
polarization, a protected alanine-derived amine was synthezised.  
Because the commonly used tert-butoxycarbonyl (Boc)-protected 
amino acid ethyl acrylate ester is sparingly soluble in water, an 
acetyl protecting group was selected to protect the amine  (4a).  
Hyperpolarization was performed accordingly to the procedure 
described with 10 mol % catalyst and 5 bar para-hydrogen pressure.  
In the experiments, the level of proton polarization achieved of the 
acetyl protected alanine derivative was approximately a factor of 
four (P = 0.48 %) higher at 20 °C and ≈ 1.5 (P = 1.02 %) at 80 °C 
relative to that obtained with the non-acetylated form, which 
suggests that the free amine group deactivates the rhodium complex, 
probably as described above.   With amine protection, the 
polarization is within 80% of the  hydroxyethyl propionate standard 
(HEP, 5a). 
Subsequently, transfer of the proton polarization to a 13C 
nucleus was investigated using the alanine derivative.  When HEP is 
polarized with a device that features optimal reaction conditions and 
mixing techniques to react para-hydrogen with the substrate and 
pulse sequences for polarization transfer, a 13C polarization of more 
than 10 % can be reached.16,45  By following the same approach, 13C 
and deuterium-labelled HEA were utilized for the synthesis of a 
labelled alanine derivative and hyperpolarized, followed by 
subsequent detection in a 9.4 T NMR magnet (Figure 3).  The 
polarizer used in this experiment has been recently described.46  The 
T1 values of 13C nuclei in carbonyl-HEP moieties in non-deuterated 
molecules and in deuterated solvent are 14–17 s (with air present at 
11.7 T, see the Supplementary Information for detailed T1 data) and 
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Figure 3. The substrate, deuterium-labeled 2c, was hyperpolarized 
using a PHIP polarizer device followed by a polarization transfer 
sequence to 13C nuclei and physical transport of the polarized 
substrate to the NMR magnet for measurement. Top trace: 
Hyperpolarized signal from 13C NMR spectroscopy and deuterium-
labeled (real spectrum) 2c.  The physical transport to the NMR 
magnet took 20s. Bottom trace: Thermally polarized signal after 16 
scans following equilibration at 9.4T and 20°C.  This spectrum was 
magnified 100 times.  The level of polarization in the hyperpolarized 
product corresponds to 4.4±1 % after transport. 
 
21.5 s in the deuterated compound at 14.1 T. These values not only 
affect the polarization transfer but are typical values necessary for in 
vivo studies; however, they are expected to be smaller in non-
deuterated solvents and in vivo.47  (As mentioned previously, a 
minimum of tens of seconds to minutes are required for transport of 
tracer molecules to targets of interest.) However, it has been pointed 
out that the relaxation times of 13C in carbonyl groups are strongly 
influenced by the chemical shift anisotropy , which is proportional to 
the magnetic field strength.48 The determined T1 = 21.5 s was 
measured at 14.1 T. Close to the earth’s magnetic field, where 
polarization transfer and transport take place, T1 is expected to be 
much longer and may be close to 2 minutes as for HEA. The yielded 
polarization was P = 4.4±1 % for the alanine derivative and P = 
10 % for HEA with 100% conversion to the desired product.  These 
values were obtained in a 9.4 T field after an unoptimized 
transportation process that took 20 s.  The 20 s time was due to the 
physical transport of the sample tube from the polarizer to the center 
of the magnet.  Improvements should be possible, shortening the 
distance from the polarizer to the magnet. Extrapolating back to time 
t = 0, which would be prior to the transportation process,  (to 
compare the polarization e.g. with Ref. [49]) the 13C polarization of 
the alanine derivative immediately following chemical reaction is 
estimated to be P = 12 %, if a T1 value of 21.5s is assumed. This 
gives an indication of the maximally achievable 13C polarization 
value but may in effect be smaller due to the T1 being greater in low 
magnetic fields during the transport. Hence, the 13C polarization 
level for this amino acid derivative may be comparative to 
polarization levels achieved with metabolites such as pyruvate.11  
This result highlights that, despite the presence of free amine groups, 
the polarization required for in vivo applications is feasible.  A 13C 
polarization of P = 12 % would correspond to a signal enhancement 
of ≈ 86,000 compared to thermal polarizations in a standard clinical 
MRI scanner (B0 = 1.5 T) or ≈ 17,000,000 at 5 mT (see the field 
strength of interest in Ref. [49]). Key to achieving such high levels 
of polarization for amino acid derivatives is the use of the sequence 
introduced by Goldman et al.16  This sequence works perfectly for 
the demonstrated derivatives but may not always be applicable for 
some amino acid derivatives, as discussed in the supplementary 
information. 
Conclusions 
The N-unprotected α-amino acid ethylacrylate esters based on 
glycine, alanine and glutamine with hyperpolarizable PHIP 
moieties were successfully synthesized and applied. The 
alanine derivative yielded 13C polarization levels in sufficient 
concentrations (10 mM) in deuterated water and sufficient 
signal for in vivo applications.9,19  The high polarization, which 
correlates with the decrease of free amine moieties in the 
synthesized molecules, indicates a gain of catalyst activity 
during the hydrogenation reaction. Our findings suggest that 
amino acid based acrylates can potentially serve as new 
contrast agents either by themselves or as labelled “building 
blocks” within peptides that retain partial bioactivity with a 
limited number of unprotected amine groups. Although, amino 
acid derivatives are likely to be taken up by cells, it is unclear 
whether the derivatives take part in metabolic processes that 
can be observed. Work is currently underway in our laboratory 
to investigate the metabolic behavior and to extend this method 
to small cancer-binding peptides that may be of particular 
interest in combination with recently developed nanoparticles 
showing significant level of polarization utilizing 
heterogeneous PHIP in water, thereby mitigating catalyst 
toxicity effects.50 
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S1 Materials and Methods 
 
Chemicals 
N,N’-Dimethylformamide (DMF), diethyl ether methylene chloride (DCM), sodium 
bicarbonate (NaHCO3) and concentrated HCl (10 M) were purchased from Thermo Fisher 
Scientific. Absolute methanol under inert gas, pentane, trifluoroacetic acid (TFA), 
Dicyclohexylcarbodiimide (DCC), dimethylaminopyridine (DMAP), Boc-Gly-OH (1), 
Boc-Ala-OH (2), Ac-Ala-OH (4), 2-hydroxyethyl acrylate (5), bis(norbornadiene) 
rhodium(I) tetrafluoroborate (6) and 1,4-Bis[(phenyl-3-propanesulfonate) phosphine] 
butane disodium salt (7) were purchased from Sigma-Aldrich. Boc-Gln-Xan-OH (3) was 
purchased from Bachem and CDCl3 and D2O (99.8%) from Cambridge isotopes. All 
chemicals were used as received without further purification.  
NMR Spectroscopy 
NMR spectra were recorded on either a Bruker AV600, a Bruker DRX500 or Bruker 
AV500 with cryoprobe. All experiments were performed at room temperature and the 
chemical shift data are reported in ppm for 1H and 13C spectra relative to tetramethylsilane 
or 4,4-dimethyl-4-silapentane-1-sulfonic acid. 
Mass Spectrometry 
Mass Spectrometry was performed on a LCT Premier XE of Micromass MS Technologies   
by electrospray ionization. Masses are given in m/z and were compared to the exact 
calculated mass. 
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S2 Synthetic procedures 
 
Synthesis of 1a 
In 15 mL methylene chloride, 1.0 mmol (175.2 mg) Boc-Gly-OH and 0.25 mmol (30 mg) 
DMAP were dissolved and 1.0 mmol (116.1 mg, 114.8 µL) 2-hydroxyethyl acrylate 
added. The solutions was cooled to 0°C and 1.1 mmol (227.0 mg) 
dicyclohexylcarbodiimide in 5 mL methylene chloride added. It was stirred at 0°C for 1 
hour, was subsequently allowed to warm up to room temperature and stirred for an 
additional 4 hours. Afterwards, the solution was concentrated to dryness, the residue taken 
up in 15 mL methylene chloride, filtered and washed two times with 5 mL HCl in water 
(0.5 M) and two times with a saturated aqueous NaHCO3 solution.  The organic phase was 
collected, residual solvent removed and the product further purified by column 
chromatography with 95% DCM and 5% MeOH. The product was received as colorless 
oil. 1H NMR (600 MHz, [D]CDCl3, 25°C): δ=6.32 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.07 
(dd, 3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.87 (d,  3J(H,H)=10.7 Hz, 1H; CH), 
4.37 (m, 4H; CH2,CH2), 3.93 (2d, 2J(H,H)=9.0 Hz, 2H; CH2), 1.43 ppm (s, 9H, 3CH3); 13C 
NMR (151 MHz, [D]CDCl3, 25°C): δ=170.45, 165.74, 155.58, 134.47,127.72, 79.95, 
62.80, 61.87, 42.19, 28.16 ppm; MS: m/z (%):calculated: 296.1110, found: 296.1108 
[M+Na]+.  
 
Synthesis of 2a 
Synthesis of 2a was achieved according to the same procedure as described for 1a by 
using 2 as a reactant instead of 1. The product was received as colorless oil. 1H NMR 
(600 MHz, [D]CDCl3, 25 °C): δ=6.32 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.07 (dd, 
3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.87 (d,  3J(H,H)=10.7 Hz, 1H; CH), 4.37 
(m+q, 4H+1H; CH2,CH2,CH), 1.43 (s, 9H, 3CH3), 1.37 ppm (d, 3J(H,H)=7.4 Hz, 3H, 
CH3); 13C NMR (151 MHz, [D]CDCl3, 25°C): δ=173.08, 165.70, 154.96, 131.40,127.75, 
79.77, 62.70, 61.89, 49.04, 28.17, 18.43 ppm; MS: m/z (%):calculated: 310.1266, found: 
310.1275 [M+Na]+.  
 
Synthesis of 3a 
0.5 mmol (mg) 3 and 0.25 mmol (30 mg) DMAP were dissolved in 0.5 mL DMF, 
followed by addition of 0.5 mmol (58.1 mg, 57.4 µL) 2-hydroxyethyl acrylate and 15 mL 
DCM. The solutions was cooled to 0°C and 1.1 mmol (227.0 mg) 
dicyclohexylcarbodiimide in 5 mL methylene chloride added. It was stirred at 0°C for 1 
hour, was subsequently allowed to warm up to room temperature and stirred for an 
additional 5 hours. Afterwards, the solution was concentrated to dryness, the residue taken 
up in 15 mL methylene chloride, filtered and washed two times with 5 mL HCl in water 
(0.5 M) and two times with a saturated aqueous NaHCO3 solution.  The organic phase was 
collected, residual solvent removed, washed with pentane and the product further purified 
by column chromatography with 95% DCM and 5% MeOH. The product was received as 
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a colorless solid. 1H NMR (500 MHz, [D]CDCl3, 25°C): δ= 7.47 (m, 2H, CH), 7.30 (m, 
2H, CH), 7.11 (m, 4H, CH), 6.52 (m, 1H, CH),  6.34 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.03 
(dd, 3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.78 (d,  3J(H,H)=10.7 Hz, 1H; CH), 
4.35 (m+t, 4H+1H; CH2,CH2,CH), 2.29 (m, 2H, CH2), 2.21 (m, 1H, CH), 2.04 (m, 1H, 
CH), 1.41 ppm (s, 9H, 3CH3); 13C NMR (126 MHz, [D]CDCl3, 25°C): δ=171.99, 170.68, 
165.73, 155.40, 151.03, 131.59, 129.51, 129.15, 127.58, 123.48, 120.95, 116.52, 80.04, 
63.05, 61.87, 52.91, 43.84, 32.34, 29.60, 28.26 ppm; MS: m/z (%):calculated: 547.2056, 
found: 547.2036 [M+Na]+.  
 
Synthesis of 4a 
Synthesis of 4a was achieved according to the same procedure as described for 3a by 
using 4 as a reactant instead of 3. The product was received as colorless oil. . 1H NMR 
(500 MHz, [D2]D2O, 25°C): δ=6.32 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.07 (dd, 
3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.87 (d,  3J(H,H)=10.7 Hz, 1H; CH), 4.32 
(m, 4H; CH2,CH2), 4.27 (q, 3J(H,H)=7.4 Hz, 1H, CH), 1.87 (s, 3H, CH3), 1.26 ppm (d, 
3J(H,H)=7.4 Hz, 3H, CH3); 13C NMR (126 MHz, [D2]D2O, 25°C): δ=174.38, 173.38, 
167.99, 132.80, 127.07, 63.27, 62.46, 48.66, 21.28, 15.64 ppm; MS: m/z (%):calculated: 
252.0848, found: 252.0852 [M+Na]+.  
 
Amine-deprotection of 1a and 2a 
 
The Boc-group of 1a and 2a was removed by dissolving them in excess of a 1:1 by 
volume mixture of DCM and TFA and subsequent stirring for 30 minutes at room 
temperature. The residues were taken up in deionized water, filtered and the solvent 
removed under vacuum to yield product 1b and 2b as colorless oils. All deprotected 
derivatives were found to degrade rapidly and were stored under inert gas at 4°C. 1b: 
1H NMR (500 MHz, [D2]D2O, 25°C): δ=6.32 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.07 (dd, 
3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.87 (d,  3J(H,H)=10.7 Hz, 1H; CH), 4.42 
(m, 4H; CH2,CH2), 3.82 ppm (s, 2H; CH2); 13C NMR (126 MHz, [D2]D2O, 25°C): 
δ=168.05, 167.80, 132.67, 127.00, 64.10, 62.34, 39.85 ppm; MS: m/z (%):calculated: 
174.0766, found: 174.0762 [M+H]+. 2b: 1H NMR (500 MHz, [D2]D2O, 25°C): δ=6.32 (d, 
3J(H,H)=17.4 Hz, 1H; CH), 6.07 (dd, 3J(H,H)=17.4 Hz, 3J(H,H)=10.7 Hz, 1H; CH), 5.87 
(d,  3J(H,H)=10.7 Hz, 1H; CH), 4.40 (m, 4H; CH2,CH2), 4.09 (q, 3J(H,H)=7.4, 1H, CH); 
1.43 ppm (d, 3J(H,H)=7.4, 3H; CH3); 13C NMR (126 MHz, [D2]D2O, 25°C): δ=170.36, 
168.02, 132.70, 127.00, 64.21, 62.32, 48.56, 14.87 ppm; MS: m/z (%):calculated: 
188.0923, found: 188.0915 [M+H]+. 
 
 
Amine-deprotection of 3a 
 
3a was dissolved in an excess of a 1:1: by volume mixture of DCM and TFA. After 5 
minutes of stirring at room temperature the solvents were removed under vacuum. 
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Diethyl ether was added (2mL) twice and decanted. The remaining residue was washed 
three times with pentane and yielded 3b as colorless wax. 1H NMR (500 MHz, [D2]D2O, 
25°C): δ=6.32 (d, 3J(H,H)=17.4 Hz, 1H; CH), 6.07 (dd, 3J(H,H)=17.4 Hz, 3J(H,H)=10.7 
Hz, 1H; CH), 5.87 (d,  3J(H,H)=10.7 Hz, 1H; CH), 4.40 (m, 4H; CH2,CH2), 4.08 (t, 
3J(H,H)=7.0, 1H, CH), 2.36 (m, 2H, CH2),  2.09 ppm (m, 2H, CH2); 13C NMR (126 MHz, 
[D2]D2O, 25°C): δ=176.57, 169.40, 167.96, 132.74, 126.97, 64.32, 62.24, 51.99, 30.08, 
25.15; MS: m/z (%):calculated: 245.1102, found: 245.1105 [M+H]+. 
 
 
Synthesis of the water soluble PHIP catalyst 
 
 1,4-bis-[(phenyl-3-propane sulfonate) phosphine]butane (norbornadiene) 
rhodium(I)tetrafluoroborate (8), which has previously been used as water soluble PHIP 
catalyst has been synthesized in a different procedure as reported:S1 Under argon 
atmosphere, in two different schlenk flasks, 10 µmol (7.5 mg) of 6 and 10 µmol (11.3 mg) 
of 7 were dissolved in 5 mL absolute methanol. After stirring for 30 minutes, 7 was 
slowly added over 1 minute to 6 and stirring continued for 1 hour followed by 
concentration to dryness under vacuum. 
 
 
S3 NMR spectra 
 
NMR spectra are shown of the reactants (1b-3b, 4a), which have been used for the 
hyperpolarization experiments.  
 
 
Fig. S1. 1H NMR spectrum of 1b at B0 = 11.7 T (500 MHz 1H frequency) acquired with 8 
scans. 
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Fig. S2. 13C NMR spectrum of 1b at B0 = 11.7 T (126 MHz 13C frequency) acquired with 
64 scans. 
 
 
Fig. S3. 1H NMR spectrum of 2b at B0 = 11.7 T (500 MHz 1H frequency) acquired in a 
single scan. 
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Fig. S4. 13C NMR spectrum of 2b at B0 = 11.7 T (126 MHz 13C frequency) acquired with 
128 scans 
 
 
Fig. S5. 1H NMR spectrum of 3b at B0 = 11.7 T (500 MHz 1H frequency) acquired with 8 
scans 
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Fig. S6. 13C NMR spectrum of 3b at B0 = 11.7 T (126 MHz 13C frequency) acquired with 
512 scans 
 
 
Fig. S7. 1H NMR spectrum of 4a at B0 = 11.7 T (500 MHz 1H frequency) acquired with 8 
scans. 
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Fig. S8. 13C NMR spectrum of 4a at B0 = 11.7 T (126 MHz 13C frequency) acquired with 
512 scans. 
 
 
S4 Para-hydrogen experiments 
 
Proton para-hydrogen experiments were performed on a Bruker AV600 spectrometer 
(B0 = 14.1 T). Para-hydrogen of about 95% para-state enrichment was produced using a 
commercial polarizer located at Cedars Sinai Medical Center.S2 Samples were prepared in 
5 mm J. Young tubes from New Era under inert gas with sample (1b-3b, 4a) 
concentrations of 25 mM and 2.5 mM catalyst concentration in 0.5 mL D2O. Each sample 
was pressurized with 5 bars of para-hydrogen, shaken for 10 s in the earth’s magnetic 
field (ALTADENA conditions) and transported to the center of the magnet within 10 s, 
where the spectrum was recorded in a single scan (45°-pulse). The experiments were 
repeated three times with different samples. After the hyperpolarization experiment, a 
spectrum was recorded with the formed product in thermal equilibrium, the signal 
enhancement and the corresponding nuclear magnetic polarization calculated. All 
experiments were conducted at pH = 6.5±0.5. Polarization transfer experiments were 
performed on a home-built polarizerS2 with a 10 mM solution of the unprotected alanine 
derivative and 2.2 mM catalyst concentration. The sample was heated up to 60°C and 
mixed with 5 bars of para-hydrogen. Subsequently a polarization sequence introduced by 
Goldman et al. was applied.S3  After a 20 s transport the NMR signal was detected in a 9.4 
T 94/20 Bruker Biospec. This experiment was performed twice after optimization of the 
pulse sequence. In order to determine the polarization, the hyperpolarized signal was 
compared to its signal in thermal equilibrium averaged 200 times.  J-couplings and 
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parameters applied for the sequence are as follows (refer to scheme S1 for the derivative) 
and a schematic drawing of the sequence can be found in figure S9: 
 
Scheme S1. Alanine-derivative that was polarized at the indicated 13C nuclei using a 
polarization transfer sequence. 
 
J-couplings: 3JH,H = 7.24 Hz; 3J13C,H = -5.62 Hz; 2J13C,H = 7.57 Hz 
 
 
 
Fig. S9. Schematic of the Goldman sequence used. Grey bars indicate 180° pulses at one 
fourth and three forth of the evolution periods. The black bars are the pulses important for 
the polarization transfer.S5 
 
The timings are: t1 = 28.28 ms , t2 = 36.20 ms, t3 = 50.34 ms 
 
S5 Relaxation times of the investigated molecules 
 
The longitudinal relaxation times (T1) of the synthesized molecules were investigated after 
hydrogenation with an AV500 system (B0 = 11.7 T) with cryoprobe for the protonated 
derivatives with an inversion recovery experiment and one scan. For carbon experiments 8 
scans were used with an inversion recovery experiment with inverse gated decoupling . 
The T1 for the deuterated and 13C labelled derivative was recorded with an AV600 system 
(B0 = 14.1 T) with 1 scan for protons and 8 scans for carbon. All experiments were 
performed at room temperature. HEP, Ala-HEP and Ac-Ala-HEP were investigated in 
D2O in the presence of air whereas for solubility and stability reasons T1 of the N-
protected Gly-HEP and Gln-HEP derivatives were measured in methanol-d4. The pH of 
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the samples was 6.5±0.5 and the catalyst concentration 10 mol% of the material, which 
means 2.5 mM. 
 
 
HEP: 
 
 
 
                 Table S1. Longitudinal 1H relaxation times of HEP 
 
1H position a b c d 
 
T1/s 
 
4.0 
 
3.5 
 
2.3 
 
2.1 
     
 
Table S2. Longitudinal 13C relaxation times of HEP 
 
13C position 1 2 3 4 5 
 
T1/s 
 
 5.5 
 
4.6 
 
15.9 
 
1.9 
 
2.0 
      
 
Ala-HEP: 
 
 
 
 
Table S3. Longitudinal 1H relaxation times of Ala-HEP 
 
1H position a b c d e f 
 
T1/s 
 
4.1 
 
3.0 
 
0.9 
 
0.9 
 
        5.9 
 
       1.2 
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Table S4. Longitudinal 13C relaxation times of Ala-HEP 
 
13C position 1 2    3   4  5  6 7 8 
 
T1/s 
 
  5.9 
 
5.8 
 
1 14.2* 
 
1.0 
   
 
 1.1 
 
 10.2 
 
 2.4 
 
1.3 
         
*T1 for the deuterated derivative corresponds to 21.5s 
 
 
Ac-Ala-HEP: 
 
 
 
Table S5. Longitudinal 1H relaxation times of Ac-Ala-HEP 
 
1H position a b c d e f 
 
T1/s 
 
3.4 
 
3.2 
 
 2.4* 
 
1.0 
 
     2.4* 
 
      0.7 
       
*chemical shift values of c and d are merged. Therefore the values reported reflect a time extracted from a 
monoexponential fit over the two proton signals 
 
Table S6. Longitudinal 13C relaxation times of Ac-Ala-HEP 
 
13C position 1 2    3   4  5  6 7 8 
 
T1/s 
 
  4.8 
 
4.3 
 
1 15.6 
 
 0.8 
   
 
 0.9 
 
 4.2 
 
 4.3 
 
1.1 
         
 
Boc-Gly-HEP: 
 
 
 
Table S7. Longitudinal 1H relaxation times of Boc-Gly-HEP 
 
1H position a b c d e 
 
T1/s 
 
5.5 
 
5.1 
 
 2.0 
 
1.7 
 
        1.7 
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Table S8. Longitudinal 13C relaxation times of Boc-Gly-HEP 
 
13C position 1 2    3   4  5  6 7 
 
T1/s 
 
  6.3 
 
6.1 
 
1 16.7 
 
 1.6 
   
 
 1.5 
 
 11.1 
 
   1.8 
        
 
 
Boc-Gln(Xan)-HEP: 
 
 
 
 
 
Table S9. Longitudinal 1H relaxation times of Boc-Gln(Xan)-HEP 
 
1H position a b c d e f g 
 
T1/s 
 
  3.6 
 
2.8 
 
1.2 
 
1.2 
 
     2.0 
 
    4.3 
 
    4.3 
        
 
Table S10. Longitudinal 13C relaxation times of Boc-Gln(Xan)-HEP 
 
13C position 1 2    3    4    5  6 7 8   9 10 
 
T1/s 
 
  6.6 
 
4.8 
 
115.6 
 
 0.4 
   
 
  0.4 
 
 7.9 
 
 3.3 
 
1.8 
 
2.9 
 
 
11.1 
           
 
S6 Catalyst decomposition 
 
When an NMR spectrum is recorded as part of a PHIP experiment in which the reaction 
mixture was heated up to 80 °C, additional hyperpolarized peaks could be observed at 0.9, 
1.8, 3.1 and 6.2 ppm. Norbornadiene is part of the used metal complex that catalyzes the 
hydrogenation of the amino acid derivatives. The observed additional peaks correspond to 
norbornene indicating that at elevated temperature the norbornadiene is partly 
hydrogenated as the catalyst decomposes.S4,S5 Figure S10 shows a 1H NMR spectrum of 
the hyperpolarized Ala-HEP derivative and hyperpolarized norbornene.  
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Fig. S10. 1H NMR spectrum of hyperpolarized norbornene and Ala-HEP at B0 = 14.1 T 
(600 MHz 1H frequency) after a 45° pulse. Asterisks indicate the propionate part of the 
hyperpolarized amino acid derivative.  
 
 
S7 Remarks on previous amino acid PHIP  
 
PHIP studies on amino acids (non-derivatives) in water have been demonstrated as a proof 
of principle, but the achieved polarization showed only small improvements over thermal 
equilibrium conditions, which prohibited any useful in vivo applications.S6 Currently, the 
most potent r.f. polarization transfer sequence from 1H to 13C was developed by Goldman 
and coworkers.S3 Except for the previously polarized γ-aminobutyric acid (GABA), it is 
unlikely that this sequence can be used to generate high polarization levels in the carbonyl 
13C (typically a long-lived 13C species) of the reported unprotected amino acids. This is 
due to the small J-couplings (in particular of 4J of aliphatic protons to 13C) leading to 
unfavorable conditions (e.g., timing and angle) with regards to transfer of proton 
polarization (see above for pulse sequence details or ref [S3]). γ-aminobutyric acid has the 
right structure for efficient polarization transfer from protons to the desired long-lived 
carbonyl 13C.  But the chemical reaction appears to be too slow to efficiently transfer spin 
order of p-H2 and it is necessary to protect the catalyst by working in a very acidic 
environment to achieve any polarization at all.S3 Working in an acidic environment, in the 
context of potential in vivo applications, means that the polarized substrate needs to be 
diluted in a buffer as an additional step before injection, which may be a source of 
polarization loss. No reported research has achieved a 13C PHIP polarization of N-
unprotect amino acids on the order of 1%, a prerequisite for in vivo applications. 
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S8 Toxicity and Metabolic considerations of hydrolysis 
 
Previous PHIP studies utilizing esters revealed that esters are quickly taken up in cells and 
are hydrolyzed fast by enzymatic processes.S7 As the synthesized amino acid derivatives 
are based on esters we would like to provide some considerations regarding the time of 
the hydrolysis, potential metabolites and their potential toxicity.  
 The synthesized derivatives contain two ester moieties that may potentially be 
hydrolyzed. It is plausible that the following chemicals could be observed due to 
enzymatic hydrolysis: free amino acid, ethylene glycol and propionic acid. Ethylene 
glycol and propionic acid originate from HEP. The amino acids used in this study can be 
seen as non-toxic as glycine, glutamine and alanine are metabolites in the human body. 
Ethylene glycol has been identified to have toxic effects on humans. Studies have revealed 
that a threshold for ethylene glycol to have toxic effects on humans is a concentration of 
about 3.2 mM in the plasma.S8 In typical in vivo experiments utilizing hyperpolarized 
contrast agents, concentrations of 25-300 mM in 1 mL are administered.S9 Considering 
that humans carry multiple liters of blood plasma, the concentration of formed ethylene 
glycol in a potential in vivo experiment is more than one order of magnitude lower than 
the described threshold and thus the expected toxicity should be low. Propionic acid is a 
metabolite that is transformed into succinyl-CoA, which is an intermediate of the citric 
acid cycle.S10 Therefore, propionic can be seen as a substrate with very low toxicity and 
can also be seen as a potential new tracer for the citric acid cycle.  
 Regarding the speed of hydrolysis, we estimate it to be on a one to several minutes 
timescale, which would be sufficient for the proposed in vivo experiments. Experiments 
with esters of fatty acids have shown that a half-life of 58 s can be expected for simple 
esters derived from ethanol.S11 With the more sterically demanding properties of the 
synthesized esters, the hydrolysis may take longer as has also been observed in the context 
of prodrug research making use of ester moieties.S12 Although parts of the potential 
contrast agents will be hydrolyzed, we expect that sufficient polarization can be delivered 
in vivo in the expected time scale.  
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